SCHEMBL4819264

SCHEMBL4819264

CC1=CC(C)(C)CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11971993 1.00
SCHEMBL891337 1.00
Methyl Alcohol SCHEMBL16568696 0.95
Formaldehyde SCHEMBL27818408 0.93
Acetaldehyde SCHEMBL11445720 0.89
SCHEMBL27946314 0.81 ALDH1A1 (0.38)
SCHEMBL11650269 0.76
SCHEMBL11433423 0.75
SCHEMBL3643635 0.74
3-Octanone SCHEMBL28192905 0.74 KMT2A (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140343145-A1 RBP1 as a Molecular Biomarker for Predicting Survival and Response to Treatment in Glioma THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-11-20 US disclosed
US-7402696-B2 Benzene compounds AJINOMOTO CO., INC. (JP) 2008-07-22 US disclosed
US-20070105899-A1 Benzene compounds AJINOMOTO CO., INC. (JP) 2007-05-10 US disclosed
US-5731320-A TREATING PATIENT IN NEED OF IMMUNOSUPPRESSIVE, ANTIINFLAMMATORY OR ANTIPROLIFERATIVE THERAPY ABBOTT LABORATORIES (US) 1998-03-24 US disclosed
US-5708002-A ASCOMYCIN ANALOGS, IMMUNOSUPPRESSANTS ABBOTT LABORATORIES (US) 1998-01-13 US disclosed
US-5643918-A MACROCYCLIC COMPOUNDS TO REVERSE DRUG RESISTANCE, VIRICIDES, ANTIINFLAMMATORY AGENTS AND FUNGICIDES ABBOTT LABORATORIES (US) 1997-07-01 US disclosed
US-5563172-A MICROBIOCIDES, FUNGICIDES, VIRICIDES, ANTIINFLAMMATORY AGENTS, ANTIGROWTH AGENTS ABBOTT LABORATORIES (US) 1996-10-08 US disclosed
EP-0689545-A4 MACROCYCLIC AMIDE AND UREA IMMUNOMODULATORS ABBOTT LAB (US) 1996-04-24 EP disclosed
EP-0689545-A1 MACROCYCLIC AMIDE AND UREA IMMUNOMODULATORS ABBOTT LABORATORIES (US) 1996-01-03 EP disclosed
US-5457111-A Side effect reduction ABBOTT LABORATORIES (US) 1995-10-10 US disclosed
WO-1994021642-A1 MACROCYCLIC AMIDE AND UREA IMMUNOMODULATORS ABBOTT LABORATORIES (US) 1994-09-29 WO disclosed